Association of anandamide and 2-arachidonoylglycerol concentrations with clinical features and body mass index in eating disorders and obesity

Abstract Background Anandamide (AEA) and 2-arachidonoylglycerol (2-AG) play a pivotal role in stimulating motivational behavior toward food and energy metabolism. Aberrant functioning of the endocannabinoid system has been observed in extreme weight conditions (EWCs), suggesting it may influence p...

Full description

Bibliographic Details
Published in:	European Psychiatry
Main Authors:	Isabel Baenas, Romina Miranda-Olivos, Roser Granero, Neus Solé-Morata, Isabel Sánchez, Antoni Pastor, Amparo del Pino-Gutiérrez, Ester Codina, Francisco J. Tinahones, José A. Fernández-Formoso, Núria Vilarrasa, Fernando Guerrero-Pérez, Rafael Lopez-Urdiales, Núria Virgili, Carles Soriano-Mas, Susana Jiménez-Murcia, Rafael de la Torre, Fernando Fernández-Aranda
Format:	Article
Language:	English
Published:	Cambridge University Press 2023-01-01
Subjects:	2-arachidonoylglycerol anandamide eating disorders endocannabinoids obesity
Online Access:	https://www.cambridge.org/core/product/identifier/S0924933823024112/type/journal_article

Similar Items

Anandamide and 2-arachidonoylglycerol baseline plasma concentrations and their clinical correlate in gambling disorder
by: Isabel Baenas, et al.
Published: (2023-01-01)

Peripheral endocannabinoids in eating disorders and obesity and its relationship with clinical and anthropometric variables
by: I. Baenas-Soto, et al.
Published: (2021-04-01)

Anandamide Inhibits Vascular Smooth Muscle Migration, Endothelial Adhesion Protein Expression and Monocyte Adhesion of Human Coronary Artery Cells
by: Elane Blessing, et al.
Published: (2024-12-01)

Endogenous Cannabinoids in Crohn’s Disease
by: Michał S. Bochenek, et al.
Published: (2024-07-01)

Endocannabinoids and related N-acylethanolamines: biological activities and metabolism
by: Kazuhito Tsuboi, et al.
Published: (2018-10-01)

From Classical to Alternative Pathways of 2-Arachidonoylglycerol Synthesis: AlterAGs at the Crossroad of Endocannabinoid and Lysophospholipid Signaling
by: Fabienne Briand-Mésange, et al.
Published: (2024-08-01)

Potent dual MAGL/FAAH inhibitor AKU-005 engages endocannabinoids to diminish meningeal nociception implicated in migraine pain
by: Adriana Della Pietra, et al.
Published: (2023-04-01)

2-Arachidonoylglycerol Reduces the Production of Interferon-Gamma in T Lymphocytes from Patients with Systemic Lupus Erythematosus
by: Luca Navarini, et al.
Published: (2022-07-01)

A review of the direct targets of the cannabinoids cannabidiol, Δ9-tetrahydrocannabinol, N-arachidonoylethanolamine and 2-arachidonoylglycerol
by: Nicholas J. D. Wright
Published: (2024-04-01)

Endocannabinoid 2-Arachidonoylglycerol Levels in the Anterior Cingulate Cortex, Caudate Putamen, Nucleus Accumbens, and Piriform Cortex Were Upregulated by Chronic Restraint Stress
by: Qing Zhai, et al.
Published: (2023-01-01)

Pitfalls and solutions in assaying anandamide transport in cells[S]
by: Sergio Oddi, et al.
Published: (2010-08-01)

Anandamide Alters Barrier Integrity of Bovine Vascular Endothelial Cells during Endotoxin Challenge
by: Carsten C. F. Walker, et al.
Published: (2022-07-01)

Dose-response effects of systemic anandamide administration in mice sequentially submitted to the open field and elevated plus-maze tests
by: A. Ribeiro, et al.
Published: (2009-06-01)

Differential inhibitory effects of endocannabinoids on neuronal firing of mouse meningeal afferents
by: Georgii Krivoshein, et al.
Published: (2025-05-01)

Investigating the Synergistic Effect of Palmitoylethanolamide and Ganaxolone in PTZ-induced Tonic-clonic Seizures
by: Hesamodin Bagheripoor, et al.
Published: (2023-03-01)

Endocannabinoid Systetm: Neuropharmacological Implications
by: Vivek Kumar Sharma, et al.
Published: (2016-06-01)

Anti-Tumorigenic Effect of a Novel Derivative of 2-Hydroxyoleic Acid and the Endocannabinoid Anandamide on Neuroblastoma Cells
by: Hana Golan, et al.
Published: (2022-06-01)

The Roles of Anandamide, Fatty Acid Amide Hydrolase, and Leukemia Inhibitory Factor on the Endometrium during the Implantation Window
by: Na Cui, et al.
Published: (2017-10-01)

2-Arachidonoylglycerol Synthesis: Facile and Handy Enzymatic Method That Allows to Avoid Isomerization
by: Roberta Ottria, et al.
Published: (2022-08-01)

Identification of Novel Predictive Biomarkers for Endometrial Malignancies: N-Acylethanolamines
by: Thangesweran Ayakannu, et al.
Published: (2019-06-01)

A novel activity of microsomal epoxide hydrolase: metabolism of the endocannabinoid 2-arachidonoylglycerol
by: Kasem Nithipatikom, et al.
Published: (2014-10-01)

Cell-autonomous and differential endocannabinoid signaling impacts the development of presynaptic retinal ganglion cell axon connectivity in vivo
by: Rodrigo Del Rio, et al.
Published: (2023-05-01)

The Influence of Anandamide on the Anterior Pituitary Hormone Secretion in Ewes—Ex Vivo Study
by: Dorota Tomaszewska-Zaremba, et al.
Published: (2020-04-01)

The Endocannabinoid System as a Potential Therapeutic Target for Pain Modulation
by: Ahmet Ulugöl
Published: (2014-06-01)

Association of the c.385C>A (p.Pro129Thr) polymorphism of the fatty acid amide hydrolase gene with anorexia nervosa in the Japanese population
by: Tetsuya Ando, et al.
Published: (2014-07-01)

Extracellular vesicles released by microglia and macrophages carry endocannabinoids which foster oligodendrocyte differentiation
by: Marta Lombardi, et al.
Published: (2024-02-01)

Evaluating Fatty Acid Amide Hydrolase as a Suitable Target for Sleep Promotion in a Transgenic TauP301S Mouse Model of Neurodegeneration
by: Shenée C. Martin, et al.
Published: (2024-02-01)

Altered Anandamide Degradation in Attention Deficit Hyperactivity Disorder
by: J Gordon Millichap
Published: (2009-06-01)

A Closer Look at Anandamide Interaction With TRPV1
by: Chante Muller, et al.
Published: (2020-07-01)

<i>Lactobacillus helveticus R0052</i> and <i>Bifidobacterium longum R0175</i> Supplementation: An Exploratory, Randomized, Placebo-Controlled Trial of Endocannabinoid and Inflammatory Responses in Female Dancers
by: Jakub Wiącek, et al.
Published: (2025-05-01)

Endocannabinoid System in Pregnancy Maintenance and Labor: A Mini-Review
by: Melissa L. Kozakiewicz, et al.
Published: (2021-06-01)

The interplay between kisspeptin and endocannabinoid systems modulates male hypothalamic and gonadic control of reproduction in vivo
by: Marianna Marino, et al.
Published: (2023-10-01)

Polymeric Nanomicelles Loaded with Anandamide and Their Renal Effects as a Therapeutic Alternative for Hypertension Treatment by Passive Targeting
by: Virna Margarita Martín Giménez, et al.
Published: (2023-01-01)

Bidirectional regulation of endocannabinoid signaling in the amygdala contributes to activation and adaptation of the stress response
by: Matthew N. Hill
Published: (2012-09-01)

Construction of machine learning tools to predict threatened miscarriage in the first trimester based on AEA, progesterone and β-hCG in China: a multicentre, observational, case-control study
by: Jingying Huang, et al.
Published: (2022-09-01)

Plasma endocannabinoid alterations in individuals with substance use disorder are dependent on the mirror effect of schizophrenia
by: Joelle eDesfossés, et al.
Published: (2012-09-01)

Endocannabinoids as potential biomarkers: It‘s all about pre-analytics
by: Daniel Kratz, et al.
Published: (2021-11-01)

Effect of central administration of indomethacin on anandamide-induced GnRH/LH secretion in the hypothalamus of anoestrous ewes
by: Tomaszewska-Zaremba Dorota, et al.
Published: (2024-07-01)

Data-driven dynamic profiles of tonic heat pain perception in pain-free volunteers are associated with differences in anandamide levels
by: Stéphane Potvin, et al.
Published: (2024-07-01)

Gut microbiota interacting with vitamin D but not anandamide might contribute to the pathogenesis of preeclampsia: a preliminary study
by: Xiao-Qiang Han, et al.
Published: (2025-02-01)